BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

Trial Profile

BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Cardiovascular disorders; Diabetes mellitus; Obesity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 Oct 2015 Planned End Date changed from 1 Dec 2015 Jun 2008 to 1 Jun 2018 as reported by ClinicalTrials.gov.
    • 24 Jul 2014 Planned End Date changed from 1 Jun 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top